NOV 11, 2015 06:00 AM PST

A Comprehensive Toxicology Screening Solution Targeted to Individual Needs

Speakers
  • Director of Clinical Chemistry, Houston Methodist Hospital, Associate Professor, Pathology and Laboratory Medicine, Weill Cornell Medical College
    Biography
      Dr. Ping Wang is currently the Medical Director of Clinical Chemistry at Houston Methodist Hospital and Associate Professor of Pathology and Laboratory Medicine at Weill Cornell Medical College. She is also Director of the ComACC-accredited Postdoctoral Fellowship Program at Houston Methodist Hospital. Dr. Wang was trained at Tsinghua University, University of Wisconsin-Madison and UCSF. She is board certified in Clinical Chemistry, Molecular Diagnostics and Toxicological Chemistry by American Board of Clinical Chemistry, for which she currently serves as Vice President and Chair of Examination Committee. She is a fellow of the National Academy of Clinical Biochemistry. She currently serves or had served on the boards of NACCCA, AACC LVDD division and TDM and Toxicology division. Dr. Wang has received many honors and awards including the Career Cornerstone Award, NACB Distinguished Abstract Award and AACC Outstanding Research Award. She has published over 60 peer-reviewed papers, abstracts and book chapters. Dr. Wang has over 10 years of experience directing and managing high complexity CLIA clinical laboratories, and is an expert in CLIA regulations, laboratory management to drive clinical efficiency, quality and outcome, clinical assay development, optimization and execution in a highly regulated environment. Besides clinical service and teaching, Dr. Wang's current research interests focus on translating novel research and start-up findings into clinical diagnostic tools. She is Principle Investigator of two NIH grants, and actively collaborates with major diagnostic companies as well as start-up ventures to develop next-generation diagnostic tools.

    Abstract:

    Drugs of abuse toxicology testing by immunoassays is widely used clinically, but also known to be inadequate for many clinical indications. In this presentation, the speaker will outline different reasons for which the provider want clinical toxicology testing, and describe a comprehensive solution using both immunoassays and LC tandem mass spectrometry to target individual needs. The speaker will also discuss the performance details of the LC tandem mass spectrometry method. After completing this activity, the learner will be able to describe several clinical needs for toxicology testing. They will also be able to describe a comprehensive solution for clinical toxicology screening, targeted to these individual needs.


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    OCT 02, 2019 11:00 AM PDT
    OCT 02, 2019 11:00 AM PDT
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    JUN 19, 2019 10:00 AM PDT
    JUN 19, 2019 10:00 AM PDT
    DATE: June 19, 2019TIME: 10:00am PDT, 1:00pm EDT As we develop new methods to create more biologically relevant models for research in understanding disease etiology and in...
    Loading Comments...
    Show Resources